Strides Pharma Inc.: Drug Recall

Recall #D-0260-2024 · 12/29/2023

Class II: Risk

Recall Details

Recall Number: D-0260-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Strides Pharma Inc.
Status: Terminated
Date Initiated: 12/29/2023
Location: East Brunswick, NJ, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 396 50-count bottles

Reason for Recall

Failed Dissolution Specifications

Product Description

Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16

Distribution Pattern

Nationwide in the USA

Other Recalls by Strides Pharma Inc.

Class II: Risk 07/09/2025

Failed Dissolution Specifications.
Class II: Risk 03/05/2025

Presence of foreign substance: Presence of Benzene.
Class II: Risk 03/05/2025

Presence of foreign substance: Presence of Benzene.
Class II: Risk 06/26/2023

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Class II: Risk 07/19/2022

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

View all recalls by Strides Pharma Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.